Verbal and visual-spatial memory problems at adolescent age after neonatal extracorporeal membrane oxygenation by Madderom, M.J. (Marlous) et al.
1 
 
Verbal and visual-spatial memory problems at adolescent age after neonatal 
extracorporeal membrane oxygenation 
Marlous J. Madderom PhD1, Femke K. Aarsen PhD1, Raisa M. Schiller MSc1, Saskia J. 
Gischler MD PhD1,  Arno F.J. van Heijst MD PhD2, Dick Tibboel MD PhD1, Hanneke 
IJsselstijn MD PhD1  
1Intensive Care and Department of Pediatric Surgery Erasmus Medical Centre-Sophia 
Children’s Hospital, Rotterdam, the Netherlands 
2Department of Neonatology Radboud University Medical Center, Nijmegen, the Netherlands 
 
 
 
 
 
Corresponding author: H. IJsselstijn 
  Intensive Care and Department of Pediatric Surgery  
  Erasmus Medical Center-Sophia Children’s Hospital 
  Room Sk-1280 
  dr. Molewaterplein 60, 3015 GJ Rotterdam, the Netherlands 
  Email: h.ijsselstijn@erasmusmc.nl 
  Telephone: +31.10.7036203 
  Fax number: 31.10.7036288 
No reprints available 
 
Conflicts of Interest and Source of Funding: The authors declare that they have no conflict of 
interest. 
Financial support was provided by Swart-van Essen Fund. 
Keywords: extraxcorporeal membrane oxygenation, adolescents, follow-up, memory, 
executive functioning, neuropsychological outcome. 
  
2 
 
Abstract 
Objectives To assess neuropsychological outcome in 17- and 18-year–old neonatal 
extracorporeal membrane oxygenation survivors.  
Design A prospective longitudinal follow-up study.  
Setting Follow-up program at the Erasmus MC-Sophia Children’s Hospital in Rotterdam, The 
Netherlands.  
Patients Thirty adolescents 17 or 18 years old, treated between 1991 and 1997, underwent 
neuropsychological assessment.  
Interventions None.  
Measurements and Main Results Attention, memory, executive functioning, visual-spatial 
functions, social-emotional functioning, and behavior were assessed with validated 
instruments, and  data were compared with reference data. Included predictors for analysis of 
adverse outcome were diagnosis, age at start extracorporeal membrane oxygenation, 
convulsions, and use of anti-epileptics. Adolescents’ performance (expressed as mean [sd] z-
score) was significantly lower than the norm on short-term and long-term verbal memory (z-
score = -1.40 [1.58], p = 0.016; z-score = -1.54 [1.67], p = 0.010, respectively), visual-spatial 
memory (z-score = -1.65 [1.37], p = 0.008; z-score = -1.70 [1.23], p = 0.008, respectively), 
and working memory (32% vs 9% in the norm population). Parents reported more problems 
for their children regarding organization of materials (z-score = −0.60 [0.90]; p = 0.03) and 
behavior evaluation (z-score = −0.53 [0.88]; p = 0.05) on a questionnaire. Patients reported 
more withdrawn/depressed behavior (z-score = −0.47 [0.54]; p = 0.02), somatic complaints 
(z-score = −0.43 [0.48]; p = 0.03), and social problems (z-score = −0.41 [0.46]; p = 0.04). 
Patients reported more positive feelings of self-esteem and an average health status. 
Conclusions Adolescents treated with neonatal extracorporeal membrane oxygenation are at 
risk of verbal, visual-spatial, and working-memory problems. Future research should focus on 
1) the longitudinal outcome of specific neuropsychological skills in adolescence and 
adulthood; 2) identifying risk factors of neuropsychological dysfunction; 3) evaluating to 
what extent “severity of illness” is responsible for acquired brain injury; and 4) effects of 
timely cognitive rehabilitation. 
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Introduction 
Neonatal extracorporeal membrane oxygenation (ECMO) stabilizes and supports critically ill 
newborns with acute and potentially reversible, respiratory failure(1). Worldwide, 
approximately 28,000 neonates have been treated with ECMO for this reason, with 75% 
surviving to discharge or transfer(2). The most common underlying conditions were 
meconium aspiration syndrome (MAS), congenital diaphragmatic hernia (CDH), and 
persistent pulmonary hypertension of the newborn(2). The best results were obtained in MAS 
patients (94% survival) and the worst in CDH patients (51%)(2).  
Survivors are at risk of serious complications, such as intra-cranial hemorrhage and 
infarctions(3). Internationally, routine neuroimaging during ECMO treatment showed 
abnormalities  in 10–59% of infants, depending on case mix and case selection(3). In the 
Netherlands, the prevalence of brain injury during ECMO treatment was 17.3% 
nationwide(4). These findings alone are sufficient reasons for early identification of survivors 
at risk of adverse neurodevelopmental outcome and  
close monitoring in the long-term. Moreover, critical illness, ECMO-treatment itself, and 
post-ECMO treatment factors may have consequences for outcomes in general.  
Various studies have reported neuropsychological outcome of neonatal ECMO 
survivors until school age, showing that intellectual outcome did not differ from that of norm 
populations but that these children had deficits in attention, memory, and visual-spatial 
functions and more frequently had special educational needs(5–9). Neonatal ECMO survivors 
might be at risk of neuropsychological problems at older age because of the poor development 
of executive functioning, such as working-memory and planning. Executive functioning is 
needed to develop academic, behavioral, and social functioning and prepare for effective 
participation in society (e.g., finding a job). As these  neuropsychological functions start to 
develop in early childhood but continue into young adulthood, these children may be at risk of 
“growing into deficits”(10). The aim of this study was to evaluate the neuropsychological 
outcome at adolescent age.  
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Materials and methods 
Population  
Data were obtained within the framework of a post-ECMO follow-up program—initiated in 
2001 in our hospital—in which children’s lung function, growth, and development are 
regularly assessed until 18 years old(11, 12). This study concerned 17- to 18-year–old 
adolescents who between February 1991 and June 1997 had been treated with neonatal 
venoarterial ECMO at the ICU of the Erasmus MC-Sophia Children’s Hospital in Rotterdam. 
In all cases, the cannula had been placed by the same surgical team in the right cervical 
region. ECMO support was given in case of severe respiratory failure and an estimated 
mortality risk of higher than 80% using the entry criteria reported by Stolar et al(13). These 
criteria were: an oxygenation index (OI) greater than 40 beyond 4 hours or an alveolar arterial 
oxygen gradient greater than 600 during 6–8 hours, with an Fio2 of 100%, and signs of 
barotraumas or acute deterioration. During the study period, these entry criteria did not 
change in our institution.  
The follow-up program is the standard of care for ECMO-treated neonates in the 
Netherlands(11, 12). The Erasmus MC Medical Ethical Review Board stated that “the 
Medical Research in Human Subjects Act (in Dutch: “WMO”) does not apply to this study 
because subjects are not being submitted to any handling nor are there rules of human 
behavior being imposed”. All participants and their parents provided permission to use the 
data.  
 
Design  
During the routine follow-up visit, structured questionnaires were used: parents of the 
adolescents provided information on socioeconomic status (SES; based on maternal 
education)(14) and ethnicity (at least one parent of Dutch/non-Dutch origin). Adolescents 
were asked about their academic achievement.  
Overall intelligence was taken as the intelligence quotient (IQ) score at age 8 or 12 
years. If IQ had been assessed at both ages, we used the IQ score assessed at 12 years. The 
follow-up program provides for a formal neuropsychological assessment by a pediatric 
psychologist. As part of the neuropsychological assessment, the parents filled out 
questionnaires in the waiting room of the hospital and the adolescents in the consultation 
room. In the first 10 years of the follow-up program, these assessments were limited and 
geared to individual needs, but from January 2012, a standard assessment battery was used for  
the neuropsychological tests (Supplemental Digital Content 1).  
The following clinical data were retrieved: underlying disease (CDH, MAS, and other 
diagnoses); gestational age; birth weight; age at start ECMO; time on ECMO; highest OI and 
mean airway pressure prior to ECMO; duration of ventilation; oxygen dependency after 
extubation (< 1wk, 1wk to 1 mo, and > 1 mo); the presence of chronic lung disease (CLD) 
(15); abnormal cranial  ultrasound (CUS: no and yes); use of morphine or other sedatives (< 1 
wk, 1 wk to 1 mo, and > 1 mo); use of muscle relaxants (no, ICU: 1 d to 1wk, and ICU: > 
1wk); the presence of convulsions (no, clinical but not tested, and confirmed on an 
electroencephalograph); use of antiepileptics (no, prophylactically, therapeutically < 1 mo, 
and therapeutically > 1 mo); and diagnosis of epilepsy at later age (no, yes, and dubious).  
 
Instruments  
Validated neuropsychological tests and questionnaires were administered in their Dutch 
versions to assess skills in different domains (see brief descriptions of the tests in the 
Supplemental Digital Content 1)(16–25).  
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Neuropsychological tests:  
1. Intelligence: Wechsler Intelligence Scale for Children.  
2. Attention: Trail Making Test and Stroop Color-Word test.  
3. Memory: subtests Rebus Learning and Auditory Comprehension of the Kaufman 
Intelligence Test; subtest digit span of the Wechsler Adult Intelligence Scale; the Rey 
Auditory Verbal Learning Test (RAVLT); and the Rey Complex Figure Test (RCFT). 
4. Executive functioning: Tower test.  
5. Visual-spatial processing: RCFT copy.  
 
Questionnaires:  
1. Executive functioning: Behavior Rating Inventory of Executive Functioning (BRIEF; 
filled out by parents).  
2. Social-emotional functioning: self-esteem: Self Perception Profile for Children 
(SPPC); health status: Pediatric Quality of Life Inventory (PedsQL).  
3. Behavior: Youth Self-Report (YSR). 
 
Data Analysis  
Differences in medical and background characteristics (Table 2) between participants and 
nonparticipants were assessed with either the Mann-Whitney U test (continuous variables) or 
the chi square test (categorical variables). The  assumption of normality were assessed. 
To enable comparison of the results of the different neuropsychological assessments, 
all  outcomes were converted into z scores (individual score minus the mean population score 
divided by the population sd). These z scores were compared with the z-score of IQ using 
paired sample t-tests. In this way, we analyzed whether the outcomes of the 
neuropsychological tests were concordant with IQ. Outcomes in z-scores on the 
neuropsychological tests and questionnaires were then compared with the z scores of the 
general population (mean z-score, 0; sd, 1) using paired samples t-tests. The difference 
between the digit-span forward and backward was assessed using the chi-square test.  
The influence of each medical variable on the neuropsychological domains on which 
the adolescents showed impaired performance compared with the general population were 
assessed using univariate linear regression analyses. Those medical variables that were found 
to be significant predictors of impaired neuropsychological outcome were then added together 
– with SES as a covariate – in a multivariate linear regression model. To check the 
assumptions for linear regression analysis and to examine the applicability of the model, 
normal probability plots of the residuals and multicollinearity was evaluated (26).  
All analyses were done using SPSS Statistics for Windows, Version 22.0 (IBM, 
Armonk, NY). A p value of 0.05 was used.  
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Results 
Patients  
Between February 1991 and June 1997, 72 neonates had been treated with ECMO. Eighteen 
(25%) had died prior to original hospital discharge (nine CDH; three MAS; six other 
diagnosis). Twenty of the 54 survivors (37%) did not attend follow-up at 17 years old: 11 
refused, four had follow-up elsewhere, two only underwent medical examination because they 
had recently been tested elsewhere (MAS with developmental delay and other diagnosis with 
intellectual disability, respectively), two had emigrated, and one was not seen because of 
organizational reasons. For 17 of these 20 patients, data on outcome or state of health were 
available. Seven had average intelligence (one with epilepsy and an infarct, one with attention 
deficit hyperactivity disorder, and one with attention deficit disorder), six had developmental 
delay, and four had intellectual disability (one with epilepsy and one with attention deficit 
hyperactivity disorder). Most medical and background characteristics did not  statistically 
differ between participants and nonparticipants; the exceptions are abnormal CUS, use of 
muscle relaxants, and the presence of convulsions (Table 1).  
 
Neuropsychological assessment and questionnaires  
Of the 34 adolescents (63%) attending follow-up, three had abnormal CUS as neonates 
(occlusion of the middle and anterior cerebral artery, subependymal hemorrhage grade 1, and 
watershed stroke, respectively).  
Of all 34 participants, three could not complete the assessment battery because of 
intellectual disability and/or behavioral problems and only filled in questionnaires on self-
esteem,  health status, and behavior (CDH with intellectual disability, MAS with intellectual 
disability and possible autism, and CDH with intellectual disability [including a chromosome 
X duplication] and autism, respectively). For organizational reasons, one other patient (CDH 
with average intelligence) was not tested and only filled in the questionnaires. The other 30 
adolescents had been assessed at the age of 17 or 18 years, but not all had performed all tests 
because of the fact that the follow-up  assessments were first geared to individual needs and 
standardized from January 2012 (Table 2). The assumption of normality was met for the 
neuropsychological data and questionnaires.  
 
Academic achievement  
Of the 30 adolescents assessed at age 17 or 18 years, five were enrolled in special education 
(15%), eight in secondary education (24%; two in preparatory vocational secondary education 
and training [in Dutch: VMBO], five in Senior General Secondary Education [in Dutch: 
HAVO], and one in University Preparatory Education [in Dutch: VWO]). Twenty adolescents 
were enrolled in senior secondary vocational education and training (60%; in Dutch: MBO), 
and one (3%) was enrolled in  first cycle higher education (in Dutch: HBO).  
In the Dutch population, 6% of adolescents who are 17 and 18 years old attend special 
education, 27% secondary education, 49% vocational education, and 18% first cycle higher 
education(27). The percentages differed significantly from the reference norm (chi-square 
test, 63.8; p < 0.001).  
 
Neuropsychological outcome  
Intelligence 
Based on outcomes of intelligence tests at 8 years (n = 3) or 12 years (n = 27), the mean IQ 
(sd)for the entire group was calculated to be 90.3 (19.4). The mean IQ z score was -0.65 
(1.29), which is significantly below the norm of the Dutch population (p = 0.03). Six children 
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had scored below 70 at age 8 or 12 years. When those six were removed from the analyses, 
the IQ of the remainder of the group was 97.5 (13.8).  
 
Attention  
Selective and divided attention did not differ from what was expected based on their IQ 
(Table 2).  
 
Memory 
The adolescents scored significantly lower (Table 2) on short-term and long-term verbal 
(RAVLT immediate and delayed recall) and visual-spatial memory (RCFT immediate and 
delayed recall) than what was expected based on their IQ (Table 2). One adolescent had visual 
problems that could primarily affect the RCFT results but was able to copy the figure (RCFT 
copy) without major problems, indicating specific visual-spatial memory problems to explain 
the low scores on the RCFT immediate and delayed recall.  
The adolescents scored significantly higher (Table 2) than expected based on their IQ 
on auditory short-term memory (digit span). However, the proportion of adolescents scoring 
lower on the backward span than on the forward span (indicative of a working-memory 
problem [28]) was significantly higher than the norm population (25) (32% vs 9%; p < 0.01).  
 
Executive Functioning 
The adolescents scored significantly higher (Table 2) than expected based on their IQ on the 
Tower  test, which measures planning.  
 
Visual-spatial processing 
Results did not differ from what was expected based on their IQ (Table 2).  
 
Questionnaires  
Executive Functioning 
Figure 1 graphically shows that the parents of the entire group on average evaluated executive  
functioning of their children to be less positive than that of the normal population (BRIEF 
organization of materials: mean [sd] = -0.60 [0.90], p = 0.03; BRIEF behavior evaluation: 
mean [sd] = -0.53 [0.88], p = 0.05).  
 
Self-Esteem  
The adolescents on average evaluated their behavior more positive than the reference 
population (SPPC behavior: mean [sd] = 0.67 [1.00], p < 0.01).  
 
Health Status  
The adolescents’ health status on average did not significantly differ from that of the normal 
population. The adolescents rated their physical, emotional, social, school, and psychosocial 
functioning similarly to healthy peers (PedsQL physical functioning: mean [sd] = 0.25 [1.06]; 
PedsQL emotional functioning: mean [sd] = 0.49 [0.92]; PedsQL social functioning: mean 
[sd] = 0.06 [1.08]; PedsQL school functioning: mean [sd] = -0.01 (1.14); PedsQL 
psychosocial functioning: mean [sd] = 0.24 [0.95]).  
 
Behavior Problems  
The adolescents on average reported more internalizing behavior problems than found in the 
normal  population (YSR withdrawn/depressed: mean [sd] = -0.47 [0.54], p = 0.02; YSR 
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somatic complaints: mean [sd] = -0.43 (0.48), p = 0.03; YSR social problems: mean [sd] = -
0.41 [0.46], p = 0.04) (Fig. 1).  
 
Factors influencing neuropsychological outcome  
Regression analyses were performed to assess whether any medical characteristics (Table 1) 
could predict the four neuropsychological outcome variables that were significantly lower 
than in the normal population (RAVLT, both immediate and delayed recall; RCFT, both 
immediate and delayed recall).  
First, univariate regression analyses with all medical variables identified four medical 
variables with an individual significant influence on one or more of the outcome variables: 
diagnosis, age at start ECMO, the presence of convulsions, and use of antiepileptics (Table 3). 
Next, multiple regression analyses were done with these four medical variables while 
correcting for SES. In the analyses, multicollinearity was evaluated. The multivariate 
regression model showed none of the medical variables to be significant predictors once 
added all together.  
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Discussion 
In this first worldwide study of neuropsychological outcome of neonatal ECMO survivors at 
adolescent age, we found that short-term and long-term verbal deficits and visual-spatial  
memory problems were present in a large proportion of these adolescents, even after 
adjustment for IQ. Impaired visual acuity could have caused the poor visual-spatial memory 
results (RCFT immediate and delayed recall) in our study. One adolescent indeed had visual 
problems but still was able to copy  the figure (RCFT copy) without major problems. 
Therefore, we believe that our results indicate specific visual-spatial memory problems in this 
population. Poorer processing skills combined with poor spatial abilities and lower scores on 
visual memory testing have been reported in 7-year-old neonatal ECMO survivors(8). Our 
findings suggest that these problems may persist into later life and could possibly affect 
academic performance and participation in society.  
In this study, the subjects performed significantly better than expected based on their 
IQ on auditory short-term memory (digit span). The digit span is comprised of a forward span 
and a backward span component. The forward component requires more from short-term 
auditory memory(29), whereas the backward component requires more from working-
memory (28) and may evoke more visuospatial image processes(30). Almost one-third of 
adolescents in this study scored significantly lower on the backward component than on the 
forward component compared to 9% in the norm population(25), suggesting deficits in 
working-memory. Deficits in working-memory have been identified in children with acquired 
brain injury as well(31).  
Concerning the adolescents’ executive functioning skills, in this study, parents 
reported more problems compared with the reference norm on the scales organization of 
materials and behavior evaluation in the adolescents. In practice, this could mean, for 
example, that they have difficulty in organizing homework assignments or do not evaluate 
their work after they have finished. We did not assess these specific executive functions, only 
planning. Further research should make clear whether the problems, reported by the parents, 
could be because of other poor executive functioning skills or (working)memory problems.  
The key brain regions supporting working-memory are the dorsolateral and 
ventrolateral prefrontal and parietal cortex(32). These regions are also involved in 
organization skills and behavior evaluation (functions that parents reported to be suboptimal 
in their children). It would, therefore, be worthwhile to specifically study these brain regions 
in neonatal ECMO survivors with the use of neuroimaging. Another brain region, the 
hippocampus, is highly and selectively susceptible to injury caused by hypoxia-ischemia 
(including ECMO treatment) (33–36) and has been shown to lead to memory dysfunctions in 
later childhood (33). This type of injury might be a partial explanation for the verbal and 
visual-spatial memory problems found in this study. Neuroimaging studies should, therefore, 
also focus on the more subcortical located hippocampus.  
Regarding social-emotional functioning, the adolescents reported more withdrawn 
behavior and somatic and social problems compared with the norm population. On the other 
hand, they had a significantly more positive feeling of self-competence. This is not an unusual 
finding. In a study with  adolescent, preterm born children, the vast majority were content 
with their activities and participation in society although most of them were neither at school 
nor employed at age 19(37). In the same vein, we have previously found that self-reported 
emotional functioning of children with congenital  anomalies treated with or without neonatal 
ECMO was not affected at the age of 8 years (7).  
We were unable to identify significant predictors of the memory problems. Still, we 
believe that “severity of illness” is a predictor for neuropsychological outcome of neonatal 
ECMO survivors, rather than ECMO treatment itself. This notion is supported by findings for 
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children with CDH who  were not treated with ECMO(7). Outcome after neonatal ECMO 
treatment is determined by many different factors: pretreatment related (e.g., congenital 
anomalies or loss of cerebral autoregulation), treatment related (such as intracranial 
hemorrhage), and posttreatment related (e.g., CLD and prolonged hospitalization)(9). 
However, a specific severity of illness scoring system for ECMO treated patients is not 
available(38). We believe that the lack of such a scoring system – together with the small 
sample size – may explain why we did not find significant predictors of outcome at older age.  
This study has some limitations. First, only 63% of participants in the follow-up 
program had been assessed at adolescent age. We started our follow-up program in 2001, and 
therefore, a large proportion of the survivors was invited a long time after their treatment. 
This resulted in a small sample. In other studies with participants born from 1996 onward, we 
had participation rates above 85%(11, 12). Bias may have occurred because significantly 
more nonparticipants than participants had abnormal CUS during ECMO(Table 1). Second, 
the fact that the average IQ was significantly below the norm is a potential source of bias. In 
previous studies in (pre)school-aged ECMO survivors, intelligence was found to be equal to 
the norm(7, 8, 11). We assume that the generally low SES in this study contributes to the low 
IQ in this group, as low SES is associated with poorer cognitive development(39). To avoid 
confounding the neuropsychological outcome, we corrected for both IQ and SES in the 
statistical analyses. Further to this issue, the use of IQ obtained at 8 and 12 years old,  rather 
than at adolescent age, could be considered a limitation. However, previous evidence that 
intelligence is stable from infancy into adolescence (40) was confirmed for the 14 adolescents 
who were evaluated at both 8 and 12 years this study. Third, we addressed selective and 
divided attention but not sustained attention. In a previous study, we found sustained attention 
problems in 8-year-old children treated with neonatal ECMO (7). Because poor sustained 
attention can interfere with memory, it is not clear whether the observed memory problems 
are primary or secondary dysfunctions. Fourth, we did not correct for multiple testing (n = 20) 
in the analyses of the neuropsychological tests. If we had done so, none of the results would 
have been significant. We decided to present the uncorrected results because this first study 
on neuropsychological outcome in neonatal ECMO survivors at adolescent age yields further 
directions for improvement of care and future follow-up studies. Fifth, we did not have a 
control group of adolescents who had similar severity of illness in the neonatal period but who 
did not undergo ECMO treatment. With two ECMO centers in the Netherlands, covering a 
relatively small geographical area, the large majority of neonates with similar severity of 
illness who are not born prematurely (i.e., born after 34 wk of gestation with birth weight > 
2,000 gm) are treated with ECMO. Therefore, it will be difficult to obtain controls with 
similar severity of illness who survived without ECMO. As an alternative, patients from 
countries with less access to ECMO treatment could serve as controls. However, variety in 
treatment protocols and neuropsychological assessments may bias the results of such a study. 
For similar reasons, we consider the use of a historic control group of infants treated before 
the ECMO era not appropriate.  
Despite the limitations, this study is of value as it is the first reporting on 
neuropsychological outcome following neonatal ECMO at 17–18 years and has important 
implications for patient care. Considering that we found neuropsychological deficits persisting 
into adolescence—thereby extending the evidence of “growing into deficit” in these 
patients—it is of utmost importance that we report outcome at this age in order to understand 
at which neuropsychological processes interventions  should be aimed.  
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Conclusions 
This study showed verbal, visual-spatial, and working-memory problems in adolescents of 
17–18 years old treated with neonatal ECMO. Furthermore, parents reported some aspects of 
executive functioning as impaired in their children. Positively, health status and sense of self-
competence did not seem affected. Considering the findings of this study in light of the 
outcome at school-age, future research should focus on 1) the longitudinal neuropsychological 
outcome, specifically of (working)  memory, 2) developing a standardized scoring system to 
quantify “severity of illness”, 3) evaluating to what extent “severity of illness” is responsible 
for acquired brain injury, and 4) evaluation of effects of cognitive rehabilitation (which is 
currently performed in our department). To achieve these  goals, it would be necessary to set 
up multicenter follow-up programs with internationally standardized assessment instruments 
and neuroimaging.  
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Tables 
 
Table 1. Medical and background variables 
 n=36 participants n=18 non-participants p value 
Diagnosis, No. (%)   0.34 
MAS 22 (61) 9 (50)  
CDH 5 (14) 1 (6)  
Other 9 (25) 8 (44)  
Gestational age in weeks, median (range) 40 (34-43) 40 (35-42) 0.94 
Birth weight in grams, median (range) 3295 (2160-4980) 3220 (2300-4360) 0.99 
Age start ECMO in hours, median (range) 28 (8-600) 25 (8-120) 0.26 
Time on ECMO in hours, median (range) 122 (47-309) 127 (72-510) 0.65 
Highest oxygenation index prior to ECMO, 
median (range) 
54 (27-130) 55 (32-95) 0.81 
Highest mean airway pressure prior to ECMO    
(cm H2O), median (range) 21 (14-28) 20 (16-26) 0.63 
Duration of ventilation in days, median (range) 10 (4-37) 10 (5-34) 0.95 
Oxygen dependency post extubation, No. (%)   0.04 
1 day- 1 week 18 (50) 7 (39)  
>1 week- 1 month 6 (17) 6 (33)  
>1 month 9 (25) -  
Missing 3 (8) 5 (28)  
CLD, No. (%)   0.16 
yes 10 (28) 1 (5)  
Missing 3 (8) 4 (22)  
Abnormal cranial ultrasound, No. (%)   0.04 
yes 5 (14) 7 (39)  
Missing - 1 (6)  
Use of morphine or other sedatives, No. (%)   0.77 
<1 week 11 (31) 6 (33)  
1 week- 1 month 21 (58) 8 (44)  
>1 month 4 (11) 3 (17)  
Missing - 1 (6)  
Use of muscle relaxants, No. (%)   0.09 
No 3 (8) -  
Intensive Care Unit 1 day- 1 week 20 (56) 14 (78)  
Intensive Care Unit >1 week 13 (36) 2 (11)  
Missing - 2 (11)  
Presence of convulsions, No. (%)   0.007 
No 25 (69) 10 (56)  
Clinical, but not tested 10 (28) 2 (11)  
Confirmed on electroencephalograph 1 (3) 6 (33)  
Use of anti- epileptics, No. (%)   0.26 
No 14 (39) 4 (22)  
Prophylactically 11 (31) 6 (33)  
Therapeutically <1 month 5 (14) 1 (6)  
Therapeutically >1 month 6 (17) 7 (39)  
Diagnosis of epilepsy at later age, No. (%)   - 
No 27 (75) -  
Yes 3 (8) -  
Dubious 3 (8) -  
Missing 3 (8) 18 (100)  
Male gender, No. (%) 17 (47) 11 (61) 0.40 
16 
 
Medical and background variables (continued)  
Ethnicity, No. (%)   0.25 
Dutch 24 (67) 8 (44)  
Missing - 9 (50)  
SES, No. (%)   0.95 
Low 19 (53) 5 (28)  
Moderate 12 (33) 4 (22)  
High 3 (8) 1 (6)  
Missing 2  (6) 8 (44)  
a. Results are presented as n (%) or median (range). MAS = meconium aspiration syndrome; CDH = 
congenital diaphragmatic hernia; other = persistent pulmonary hypertension in the newborn (n=7), 
sepsis (n=5), asphyxia (n=3), pulmonary hypoplasia due to kidney failure (n=1), respiratory syncytial 
virus (n=1); ECMO = extracorporeal membrane oxygenation; CLD = chronic lung disease as defined 
by Jobe and Bancalari(15). SES = socio-economic status based on maternal education(40).  
P value: difference between participants and non-participants; the Mann-Whitney test was used for 
continuous variables; the chi-square test was used for categorical variables. 
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Table 2. Overview of neuropsychological assessment outcome 
Neuropsychological test n IQ mean (SD) Mean (SD) p value 
     
Attention     
TMT A 22 -0.69 (1.36) -0.71 (1.75) 0.95 
TMT B   -0.90 (1.28) 0.39 
TMT B/A   -0.50 (0.93) 0.34 
Stroop 1 22 -0.69 (1.36) -0.94 (1.59) 0.18 
Stroop 2   -0.79 (1.56) 0.74 
Stroop 3   -0.90 (1.33) 0.45 
Stroop    -0.41 (1.08) 0.34 
     
Memory     
KAIT rebus learning 29 -0.59 (1.28) -0.83 (1.11) 0.38 
KAIT rebus learning delayed   -0.74 (1.56) 0.82 
KAIT auditory comprehension   -0.34 (0.87) 0.22 
KAIT auditory comprehension delayed   -0.70 (1.24) 0.63 
WAIS Digit span 22 -0.69 (1.36) -0.12 (1.12) 0.014 
RAVLT immediate 28 -0.63 (1.33) -1.40 (1.58) 0.02 
RAVLT delayed   -1.54 (1.67) 0.010 
RAVLT recognition 14 -0.66 (1.24) -0.69 (1.53) 0.76 
RCFT immediate 9 -0.47 (1.21) -1.65 (1.37) 0.008 
RCFT delayed   -1.70 (1.23) 0.008 
RCFT recognition   -1.07 (0.69) 0.20 
Executive functioning     
Tower 29 -0.64 (1.32) -0.06 (0.96) 0.03 
     
Visual spatial processing     
RCFT copy 9 -0.47 (1.21) -0.97 (1.48) 0.29 
b. n= number of adolescents assessed with that specific neuropsychological test. IQ mean (SD) = 
average z-score IQ of the adolescent group assessed with that specific test. Mean (SD) = average z-
score of the neuropsychological test. P value = outcome of the paired samples t-test between IQ and 
neuropsychological outcome. P value = significant outcome of the paired sample t-test. TMT = Trail 
Making Test; Stroop = Stroop Color Word Test; KAIT = Kaufman Adult Intelligence Test; WAIS = 
Wechsler Adolescent Intelligence Scale; RAVLT = Rey Auditory Verbal Learning Test; RCFT = Rey 
Complex Figure Test; Tower = Tower test. 
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Figures 
 
 
 
Figure 1. 
YSR = Youth Self Report. 
BRIEF = Behavior Rating Inventory of Executive Functioning. 
Z-score = Individual norm score minus the population norm score divided by the standard 
deviation of the population. 
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Supplemental Material  
 
Supplemental Digital Content 1. Descriptions of the neuropsychological tests.  
Intelligence  
Wechsler Intelligence Scale for Children (WISC-III-NL) 
Intelligence test for children between the ages 6 and 16. The test generates a full scale IQ 
(FSIQ), Total Verbal IQ (TVIQ) and Total Performance IQ (TPIQ). The IQ scores are 
derived from five verbal and five performance subtests. There are also three supplemental 
tests (1, 2).  
  
Attention  
Trail Making Test (TMT) 
This paper and pencil test consists of two parts. In the first part (part A), the subject must 
draw lines to consecutively connect numbered circles on a sheet. In the second part (part B), 
the subject must consecutively but alternately connect numbered and lettered circles on 
another worksheet. The goal of the test is to finish each part as quickly as possible.  The test 
can be administered to children and adults in the age range 6-89 years. This test measures 
visual conceptual and visuomotor tracking as well as divided attention (3, 4).  
 
Stroop Color Word Test (Stroop) 
The Stroop consists of three trials: in the first trial (Stroop 1) the subject must read color 
names, in the second trial (Stroop 2) name printed colors, and in the third trial (Stroop 3) 
name printed colors not denoted by the color name. The test can be administered to children 
and adults in the age range 8-65 years. Selective attention is measured with this test (3, 4).  
 
Memory  
Kaufman Intelligence Test (KAIT) – subtest Rebus Learning 
The subject learns a word or concept associated with a rebus (a picture that stands for a word) 
and then has to read aloud phrases and sentences that are composed of these rebuses. This is 
repeated after 30 minutes.  
This test measures short- and long-term visual/verbal associative memory. Adolescents and 
adults in the age range 14-85 years can take the test (5, 6).  
 
Kaufman Intelligence Test (KAIT) – subtest Auditory Comprehension  
The subject has to listen to a recording of a news story, then answer literal and inferential 
questions about the story. This test measures short- and long-term (after 45 minutes) verbal 
memory and verbal logic reasoning. Adolescents and adults in the age range 14-85 years can 
take the test (5, 6).  
 
Wechsler Adult Intelligence Scale – Third Edition (WAIS-III)  – subtest Digit Span  
The Digit Span consists of random number sequences that increase in length and that the 
examiner reads aloud at the rate of 1 number per second. The subject has to reproduce these 
numbers in the same order. Next, the sequences must be recalled backwards (3-5-7 becomes 
7-5-3). The first part of the test measures short-term auditory memory and short-term 
retention capacity. The second part measures auditory working memory. A difference of 4 or 
more points between forward and backward Digit Span in favor of forward is indicative of a 
working-memory problem. The test is applicable to adolescents and adults in the age range 
16-85 years (7).  
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Rey Auditory Verbal Learning Test (RAVLT) 
The RAVLT consists of five presentations with recall of a 15-word list, a sixth recall trial 
after 30 minutes, and a seventh recognition trial. This test measures memory span, short- and 
long term verbal memory, verbal recognition, learning curve, and retroactive or proactive 
interference. It can be administered to children and adults in the age range 6-89 years (8, 9).  
 
Memory and visual-spatial functioning  
Rey Complex Figure Test (RCFT) 
The RCFT consist of three trials. First the subject has to copy a complex figure. Then after 3 
and after 30 minutes the figure must be drawn from memory. Next, different figures are 
shown and the subject has to indicate whether these figures were in the original figure. This 
test measures visual integration, short- and long-term visual-spatial memory, and visual-
spatial recognition. It can be completed by children and adults in the age range 6-89 years (4, 
10).  
 
Executive functioning  
Tower Test (Tower) 
The subject must plan ahead to rearrange five colored rings in varying sizes from the initial 
position on three upright sticks to a new predetermined position in as few moves as possible. 
When two or more rings are at the same stick, the smaller ones must always be on top of the 
larger ones. Only one ring can be moved at the same time. This tests measures planning 
ability and can be administered to children and adults in the age range 8-89 years (11, 12).  
 
Behavior Rating Inventory of Executive Functioning questionnaire (BRIEF) 
This questionnaire is filled out by parents of children and adolescents between the ages of 6 
and 18 years. Different areas of executive functioning are addressed in 75 questions that form 
8 subscales: Inhibition, Cognitive Flexibility/Shifting, Emotional Control, Initiate, Working-
memory, Plan/organize, Organization of materials, Monitor. The 8 subscales make up two 
indices: Behavior Regulation Index (ability to adjust thinking and regulate emotions and 
behavior) and Metacognition Index (ability to independently carry out tasks and solve 
problems based on the judgment of own behavior). A total executive functioning score can be 
derived as well (13, 14).  
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